Form 4: Maravai LifeSciences CFO Kevin Herde Reports Tax-Related Stock Disposal
SEC Form 4 Filing
Kevin Herde, CFO of Maravai LifeSciences Holdings, Inc., reports the disposal of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On March 17, 2025, Kevin Herde, the Chief Financial Officer of Maravai LifeSciences Holdings, Inc., disposed of 8,648 shares of Class A Common Stock.
- The shares were withheld to satisfy tax withholding obligations related to the vesting of restricted stock unit awards.
- The transaction was executed at a price of $2.64 per share.
- Following the transaction, Herde directly owns 279,282 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: The document describes a routine transaction related to tax obligations, which is neither particularly positive nor negative.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. This specific filing relates to the standard practice of covering tax obligations associated with the vesting of stock-based compensation.
Key Dates
| Date | Description |
|---|---|
| 03/17/2025 | Date of transaction: disposal of shares to cover tax obligations. |
| 03/19/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Maravai LifeSciences, MRVI, Kevin Herde, CFO, Stock Disposal, Tax Withholding, Restricted Stock Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.